DUBLIN--(BUSINESS WIRE)--Research and Markets(http://www.researchandmarkets.com/research/8050cb/acne_and_related_d) has announced the addition of Global Markets Direct's new report "Acne And Related Disorders - Pipeline Review, H1 2012" to their offering.
Global Markets Direct's, 'Acne And Related Disorders - Pipeline Review, H1 2012', provides an overview of the Acne And Related Disorders therapeutic pipeline. This report provides information on the therapeutic development for Acne And Related Disorders, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Acne And Related Disorders. 'Acne And Related Disorders - Pipeline Review, H1 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.
Key Topics Covered:
- Introduction
- Global Markets Direct Report Coverage
- Acne And Related Disorders Overview
- Therapeutics Development
- An Overview of Pipeline Products for Acne And Related Disorders
- Acne And Related Disorders Therapeutics under Development by Companies
- Acne And Related Disorders Therapeutics under Investigation by Universities/Institutes
- Late Stage Products
- Comparative Analysis
- Mid Clinical Stage Products
- Comparative Analysis
- Early Clinical Stage Products
- Comparative Analysis
- Discovery and Pre-Clinical Stage Products
- Comparative Analysis
- Acne And Related Disorders Therapeutics - Products under Development by Companies
- Acne And Related Disorders Therapeutics - Products under Investigation by Universities/Institutes
- Companies Involved in Acne And Related Disorders Therapeutics Development
- Immune Technologies and Medicine
- Acne And Related Disorders - Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Combination Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Drug Profiles
- Acne And Related Disorders Therapeutics - Drug Profile Updates
- Acne And Related Disorders Therapeutics - Discontinued Products
- Acne And Related Disorders Therapeutics - Dormant Products
- Acne And Related Disorders - Product Development Milestones
- Featured News & Press Releases
- Appendix
- Methodology
Companies Mentioned:
- Johnson & Johnson
- Photocure ASA
- Allergan, Inc.
- QLT Inc.
- Valeant Pharmaceuticals International
- Perrigo Company
- GlaxoSmithKline plc
- Stiefel Laboratories, Inc.
- Cipher Pharmaceuticals Inc.
- Galderma S.A.
- Meda AB
- Paratek Pharmaceuticals, Inc.
- Revance Therapeutics, Inc.
- Helix BioMedix, Inc.
- Cosmo Pharmaceuticals S.p.A
- TopoTarget A/S
- XOMA Ltd.
- Quest PharmaTech Inc.
- Summit Corporation plc
- Phynova Group Ltd
- Syntopix Group Plc
- Phosphagenics Limited
- Foamix Ltd.
- aRigen Pharmaceuticals, Inc.
- AndroScience Corporation
- NovaLead Pharma Pvt. Ltd.
- NanoBio Corporation
- ELORAC, Inc.
- Cutanea Life Sciences
- Laboratorios SALVAT S.A.
- Braintree Laboratories, Inc.
- Maruho Co.,Ltd.
- Mimetica Pty Ltd.
- Fibrocell Sciences, Inc.
- Ausio Pharmaceuticals, LLC
For more information visit http://www.researchandmarkets.com/research/8050cb/acne_and_related_d